%PDF-1.4
%
64 0 obj
<>
endobj
61 0 obj
<>
endobj
120 0 obj
<>stream
Acrobat Distiller 4.05 for Macintosh
2005-06-06T09:18:20Z
2024-03-28T17:28:27-07:00
QuarkXPressª: AdobePS 8.8.0 (301)
2024-03-28T17:28:27-07:00
application/pdf
Heather
2004-293.july
uuid:0c4d2fa6-1dd2-11b2-0a00-4a08277d8900
uuid:0c4d2fa9-1dd2-11b2-0a00-d30000000000
endstream
endobj
50 0 obj
<>
endobj
51 0 obj
<>
endobj
65 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Thumb 30 0 R/Type/Page>>
endobj
1 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Thumb 32 0 R/Type/Page>>
endobj
4 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Thumb 34 0 R/Type/Page>>
endobj
7 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Thumb 36 0 R/Type/Page>>
endobj
10 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Thumb 38 0 R/Type/Page>>
endobj
13 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Thumb 40 0 R/Type/Page>>
endobj
16 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Thumb 42 0 R/Type/Page>>
endobj
19 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Thumb 44 0 R/Type/Page>>
endobj
150 0 obj
[154 0 R]
endobj
151 0 obj
<>stream
1 g
/GS0 gs
0 792 m
0 792 l
f
q
13.5 787.5 585 -783 re
W n
q
0 792.03 612 -792 re
W n
BT
0 0 0 1 k
/GS1 gs
/T1_0 1 Tf
-0.00011 Tc 0.02499 Tw 8 0 0 8 57 736.1941 Tm
[(15.)-875.1 (Harding )54.8 (A, Stuart-Buttle C. )17.7 (The development and role of the Read)]TJ
0 Tc 2.175 -1.25 Td
[(Codes. J )54.9 (AHIMA)-220.1 (1998;69:34-8.)]TJ
-0.00011 Tc -2.175 -1.25 Td
[(16.)-875.1 (Campbell JR, Carpenter P)110.7 (,)-0.1 ( Sneiderman C, Cohn S, Chute CG,)]TJ
2.175 -1.25 Td
[(W)79.9 (arren J. Phase II evaluation of clinical coding schemes: )]TJ
0 -1.25 TD
[(completeness, taxonomy)64.8 (, mapping, definitions, and clarity)64.8 (. CPRI)]TJ
T*
[(W)79.9 (ork Group on Codes and Structures. J )54.8 (Am Med Inform )54.8 (Assoc)]TJ
0 Tc 0 Tw T*
(1997;4:238-51.)Tj
-0.00011 Tc 0.02499 Tw -2.175 -1.25 Td
[(17.)-875.1 (T)69.9 (o)-0.1 (wnsend P)110.7 (, Phillimore P)110.7 (, Beattie )54.8 (A. Health and deprivation:)]TJ
2.175 -1.25 Td
(inequality and the North. London: Croom Helm; 1988.)Tj
-2.175 -1.25 Td
[(18.)-875.1 (Snaith RP)110.7 (, )17.7 (T)69.9 (aylor CM. Rating scales for depression and anxiety: a)]TJ
2.175 -1.25 Td
(current perspective. Br J Clin Pharmacol 1985;19:17-20S.)Tj
-2.175 -1.25 Td
[(19.)-875.1 (A)91.8 (ylard PR, Gooding JH, McKenna PJ, Snaith RP)110.7 (. )54.8 (A)-220.1 (validation)]TJ
2.175 -1.25 Td
(study of three anxiety and depression self-assessment scales.)Tj
T*
(J Psychosom Res 1987;31:261-8.)Tj
-2.175 -1.25 Td
[(20.)-875.1 (Rockhill B, Newman B, )17.7 (W)79.9 (einber)17.7 (g C. Use and misuse of population)]TJ
2.175 -1.25 Td
[(attributable fractions. )54.8 (Am J Publ Health 1998;88:15-9.)]TJ
-2.175 -1.25 Td
[(21.)-875.1 (Andersson HI, Ejlertsson G, Leden I, Schersten B. Musculoskeletal)]TJ
2.175 -1.25 Td
(chronic pain in general practice. Studies of health care utilisation in)Tj
T*
(comparison with pain prevalence. Scand J Prim Health Care)Tj
0 Tc 0 Tw T*
(1999;17:87-92.)Tj
-0.00011 Tc 0.02499 Tw -2.175 -1.25 Td
[(22.)-875.1 (Johnson J, )17.7 (W)79.9 (eissman MM, Klerman GL. Service utilisation and)]TJ
2.175 -1.25 Td
(social morbidity associated with depressive symptoms in the )Tj
0 Tc T*
[(community)64.9 (. JAMA)-220.1 (1992;267:1478-83.)]TJ
-0.00011 Tc -2.175 -1.25 Td
[(23.)-875.1 (V)110.8 (edsted P)110.7 (,)-0.1 ( Fink P)110.7 (, Olesen F)79.7 (, Munk-Jor)17.7 (gensen P)110.7 (. Psychological )]TJ
2.175 -1.25 Td
(distress as a predictor of frequent attendance in family practice: a)Tj
T*
[(cohort study)64.8 (. Psychosomatics 2001;42:416-22.)]TJ
-2.175 -1.25 Td
[(24.)-875.1 (Johansson EE, Hamber)17.7 (g K, )17.7 (W)79.9 (estman G, Lindgren G. )17.7 (The meanings)]TJ
2.175 -1.25 Td
[(of pain: an exploration of women\325)54.8 (s descriptions of symptoms. Soc)]TJ
T*
(Sci Med 1999;48:1791-802.)Tj
-2.175 -1.25 Td
[(25.)-875.1 (Barsky )54.8 (AJ, Borus JF)79.7 (. Functional somatic syndromes. )54.8 (Ann Intern)]TJ
0 Tc 2.175 -1.25 Td
(Med 1999;130:910-21.)Tj
-0.00011 Tc -2.175 -1.25 Td
[(26.)-875.1 (W)79.9 (essely S, Nimnuan C, Sharpe M. Functional somatic syndromes:)]TJ
2.175 -1.25 Td
(one or many? Lancet 1999;354:936-9.)Tj
30.825 40 Td
[(27.)-875.1 (W)79.9 (olfe F)79.7 (, Hawley DJ. Evidence of disordered symptom appraisal in)]TJ
2.175 -1.25 Td
(fibromyalgia: increased rates of reported comorbidity and )Tj
T*
[(comorbidity severity)64.8 (. Clin Exp Rheumatol 1999;17:297-303.)]TJ
-2.175 -1.25 Td
[(28.)-875.1 (Grif)17.7 (fin MR. Epidemiology of nonsteroidal anti-inflammatory )]TJ
2.175 -1.25 Td
[(drug-associated gastrointestinal injury)64.8 (. )54.8 (Am J Med 1998;104:23-9S.)]TJ
-2.175 -1.25 Td
[(29.)-875.1 (Propert KJ, Schaef)17.7 (fer )54.8 (AJ, Brensinger CM, Kusek JW)91.7 (, Nyber)17.7 (g LM,)]TJ
2.175 -1.25 Td
[(Landis JR. )54.8 (A)-220.1 (prospective study of interstitial cystitis: results of )]TJ
T*
(longitudinal follow-up of the interstitial cystitis database cohort.)Tj
T*
(The Interstitial Cystitis Database Study Group. J Urol)Tj
0 Tc 0 Tw T*
(2000;163:1434-9.)Tj
-0.00011 Tc 0.02499 Tw -2.175 -1.25 Td
[(30.)-875.1 (Hudson )54.8 (AJ. Pain perception and response: central nervous system)]TJ
2.175 -1.25 Td
(mechanisms. Can J Neurol Sci 2000;27:2-16.)Tj
-2.175 -1.25 Td
[(31.)-875.1 (Philbin EF)79.7 (, Grof)17.7 (f GD, Ries MD, Miller )17.7 (TE. Cardiovascular fitness)]TJ
2.175 -1.25 Td
[(and health in patients with end-stage osteoarthritis. )54.8 (Arthritis Rheum)]TJ
0 Tc 0 Tw T*
(1995;38:799-805.)Tj
-0.00011 Tc 0.02499 Tw -2.175 -1.25 Td
[(32.)-875.1 (Nevitt MC, Cummings SR, Kidd S, Black D. Risk factors for )]TJ
2.175 -1.25 Td
[(recurrent non-syncopal falls. )54.8 (A)-220.1 (prospective study)64.8 (. JAMA)]TJ
0 Tc 0 Tw T*
(1989;261:2663-8.)Tj
-0.00011 Tc 0.02499 Tw -2.175 -1.25 Td
[(33.)-875.1 (Hassey )54.8 (A, Gerrett D, )17.7 (W)39.8 (ilson )54.8 (A. )54.8 (A)-220.1 (survey of validity and utility of)]TJ
2.175 -1.25 Td
(electronic patient records in a general practice. BMJ)Tj
0 Tc 0 Tw T*
(2001;322:1401-5.)Tj
-0.00011 Tc 0.02499 Tw -2.175 -1.25 Td
[(34.)-875.1 (Hansell )54.8 (A, Hollowell J, Nichols )17.7 (T)74 (, McNiece R, Strachan D. Use of)]TJ
2.175 -1.25 Td
(the General Practice Research Database \(GPRD\) for respiratory)Tj
T*
(epidemiology: a comparison with the 4th Morbidity Survey in)Tj
T*
[(General Practice \(MSGP4\). )17.7 (Thorax 1999;54:413-9.)]TJ
-2.175 -1.25 Td
[(35.)-875.1 (Jick H, Jick SS, Derby LE. )17.7 (V)110.8 (alidation of information recorded on)]TJ
2.175 -1.25 Td
(general practitioner based computerised data resource in the United)Tj
0 Tc T*
(Kingdom. BMJ 1991;302:766-8.)Tj
-0.00011 Tc -2.175 -1.25 Td
[(36.)-875.1 (Pringle M, )17.7 (W)79.9 (ard P)110.7 (, Chilvers C. )54.8 (Assessment of the completeness and)]TJ
2.175 -1.25 Td
(accuracy of computer medical records in four practices committed)Tj
T*
[(to recording data on computer)54.8 (. Br J Gen Pract 1995;45:537-41.)]TJ
ET
0 0 0 1 K
53.964 76.5 m
558.972 76.5 l
S
0 0 0 0 k
52.822 69.665 64.178 -15.665 re
f*
BT
0 0 0 1 k
/T1_1 1 Tf
0 Tc 0 Tw 8 0 0 8 53.8216 56.7343 Tm
(1348)Tj
ET
0 0 0 0 k
356 69.665 203 -15.665 re
f*
BT
0 0 0 1 k
/T1_1 1 Tf
-0.00011 Tc 0.02499 Tw 8 0 0 8 424.3613 56.7343 Tm
(The Journal of Rheumatology 2005; 32:7)Tj
ET
0 0 0 0 k
/GS0 gs
103.631 81.583 407.5 -10.833 re
f*
0.5 w
/GS1 gs
103.631 81.583 407.5 -10.833 re
S
Q
Q
q
0 0 612 792 re
W n
BT
0 g
/GS2 gs
/T1_2 8 Tf
108.828 74 Td
(Personal non-commercial use only. The Journal of Rheumatology Copyright\
\251 2005. All rights reserved.)Tj
ET
Q
BT
0 g
/GS2 gs
/T1_3 1 Tf
10 0 0 10 540 17 Tm
( )Tj
0 0.48627 0.77255 rg
/GS2 gs
-7.22298 0 Td
(www.jrheum.org)Tj
0 g
/GS2 gs
-16.72996 0 Td
(Downloaded on March 28, 2024 from )Tj
ET
endstream
endobj
44 0 obj
<>stream
8;Z\79e.c'iRd%%NQ]6$n//SmjrBL*3W:$1d7f(4+E0.9T#f\AVgBF`
c_nUifIO;8@"[ON\-8S2)27h%eesTk-[Q$QE_P=k0Uq\+
d`h(W1+lLu\]>9>3768)Q*^,j']a$:]?'2a8o[gSH+ksi!KjDmu?oKYfS09MfN
AB1>Zd'0!^BPST,M:Sl]nTP!-g6G[r,bdtpq,&=E3iqL8ep@%Ubjc/hcn\nh$V@.i
SD'p)(&do@3R0F2^nfUu900C!r8,m/)N4TJ1?\_'P:I;^0@/?8fb^F_XQ8GCO!OtsqdM`E&5J9dkbN#cnCkFa!Htg4*fgf[oT(4o
fr?*gElKjfooZ*#Eu/"<_4*iP5>liJm;i94U"hcS]P<'-U4nLu-9i*J7\e@E1`D?C
UX?RZ]7F6<\(s7`f>Y3R^=C1ACnjkeDZIqU9@<~>
endstream
endobj
48 0 obj
[/Indexed/DeviceRGB 255 47 0 R]
endobj
47 0 obj
<>stream
J,g]g+e/h_!_gCtO=0f)$P%cIi8Zdfc5&3j_8$7g.@L`YKUJNGBP\poR=_;Dl'P(T
(7Boo^^S:71(MN]ZQX/+Cbu.lK"p74pe1T%s.DY%&\1TdJhr54.M9au6>79n6`Q:4
PbLSZTLEE(8E@'*1mg_*eTnN*;*'V3+gm-EEetX%;Bo$ur2ss*N`.-!.kG_q6GDD'
dKoL!8Ka#EV,@V!\j8ZFbp6EE<9cn=N6j0nf;(&;QU6bUD')c@\
9-d\DA=cZ0Q>gIM$$;cd2O@&a;X,Nn_aP(]I1aRc(K1^ue>
gF/(+GaKo$qneLWDrQ#;5\S(\$q'4Q,85`-8;S(=Z"WSBOV*FM)4,?B],R
endstream
endobj
81 0 obj
<>
endobj
67 0 obj
<>
endobj
103 0 obj
<>
endobj
125 0 obj
<>
endobj
68 0 obj
<>
endobj
94 0 obj
<>stream
HtTkPWaqinĨD1P d5+"FPE`A^3{@
"ÛXͮE|
D)|FW+N*ېHvVuo{6D3BW/$^T؉D,;.Smv<K~Lg nGtMH"g—lf4n~'wD\<&76fIznurl.5EJS-8D.l=֫udǜFϩ4*NR䔴T5̩Kq!OiT:Zk/h'MÜROa/Ɩ`
)`X&}$p115ցDDD?ۭ;oZҋgDD,)$-^z={4igpWӵӟʼe3"g<>s#Cx"䉡R([C*!A,jVQբmJJv
䤨\'1xS/n,xIBh;Ïᝡz
C<|K
vC#3?Twg/5ğ˶WЖ: